Biotech Values

[DewDiligence]

PTLA—Inasmuch as PRT4445 was able to inhibit Eliquis (#msg-87707322), it would have been very surprising if it didn’t also inhibit Xarelto, since Eliquis and Xarelto work exactly the same way.

PRT4445 still has a long way to go, and (as noted in #msg-91053501) I’m skeptical that the FDA will approve it based on only phase-2 PoC studies and a single PD study, as PTLA contends.